J0575 HCPCS Level II Code: Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
Medicare Coverage & Payment
- CMS short descriptor: Bupren/nal over 10mg bupreno
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Payment category: Service not separately priced (pricing indicator 00)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2016
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Contextual Map
Every relationship of J0575 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (35)
- J0500 — Injection, dicyclomine hcl, up to 20 mg[Sibling]— CMS HCPCS Level II code set
- J0515 — Injection, benztropine mesylate, per 1 mg[Sibling]— CMS HCPCS Level II code set
- J0517 — Injection, benralizumab, 1 mg[Sibling]— CMS HCPCS Level II code set
- J0520 — Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg[Sibling]— CMS HCPCS Level II code set
- J0525 — Injection, cefotetan disodium, 10 mg[Sibling]— CMS HCPCS Level II code set
- J0528 — Injection, fosfomycin disodium, 20 mg[Sibling]— CMS HCPCS Level II code set
- J0558 — Injection, penicillin g benzathine and penicillin g procaine, 100,000 units[Sibling]— CMS HCPCS Level II code set
- J0561 — Injection, penicillin g benzathine, 100,000 units[Sibling]— CMS HCPCS Level II code set
- and 27 more
Change history
- January 1, 2015 — Added to the code set [Change history]— CMS release files (code change ledger)
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, descriptors, coverage and pricing attributes Official source data
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS HCPCS quarterly update files, ingested into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Change history
- January 1, 2015Added to the code setBuprenorphine/naloxone, oral, greater than 10 mg buprenorphine
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J0575 in its code family, with their registry titles.
- J0570 — Buprenorphine implant, 74.2 mg
- J0571 — Buprenorphine, oral, 1 mg
- J0572 — Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
- J0573 — Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
- J0574 — Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
- J0576 — Injection, buprenorphine extended-release (brixadi), 1 mg
- J0577 — Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
- J0578 — Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
- J0582 — Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
- J0583 — Injection, bivalirudin, 1 mg